Your browser doesn't support javascript.
loading
Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial.
Corbin, Karen D; Carnero, Elvis A; Allerton, Timothy D; Tillner, Joachim; Bock, Christopher P; Luyet, Pierre-Philippe; Göbel, Britta; Hall, Kevin D; Parsons, Stephanie A; Ravussin, Eric; Smith, Steven R.
Afiliação
  • Corbin KD; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Carnero EA; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Allerton TD; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
  • Tillner J; Translational Medicine, Sanofi, Frankfurt, Germany.
  • Bock CP; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Luyet PP; R&D, Sanofi, Frankfurt, Germany.
  • Göbel B; R&D, Sanofi, Frankfurt, Germany.
  • Hall KD; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
  • Parsons SA; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Ravussin E; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
  • Smith SR; AdventHealth Translational Research Institute, Orlando, Florida, USA.
Obesity (Silver Spring) ; 31(2): 350-362, 2023 02.
Article em En | MEDLINE | ID: mdl-36695055

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Glucagon / Obesidade Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Obesity (Silver Spring) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Glucagon / Obesidade Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Obesity (Silver Spring) Ano de publicação: 2023 Tipo de documento: Article